- Helen Bushby
- Entertainment and arts editor
Fonda revealed in September that she had been diagnosed with non-Hodgkin’s lymphoma
Actress Jane Fonda said she feels “blessed” and “very lucky” to have her cancer in remission. She added that she might now stop the chemotherapy.
The actress, who turns 85 on Wednesday, described the news as “the best birthday present ever”.
“Thank you all of you who prayed and sent good thoughts my way,” she wrote in a blog post. “I’m sure they played a part in bringing regarding this good news.”
The star was receiving treatment for non-Hodgkin lymphoma.
She told her 1.9 million followers on Instagram in September that it was “a very treatable cancer…so I feel very lucky,” adding that she will undergo chemotherapy over six months.
Speaking of her cancer being in remission and following her oncologist told her her chemotherapy might be over, she added: “I am especially happy because while the first four chemo treatments were easy for me, just a few days of tiring, the treatment session The last chemo was tough and lasted two weeks, which makes it hard to get a lot done.”
image copyright Getty Images
Jane Fonda said in September that she would receive six months of chemotherapy
Non-Hodgkin’s lymphoma is a less common cancer that develops in the lymphatic system, which is the body’s vast network of vessels and glands.
The Academy Award-winning actress made her debut in 1960 and is known for films such as Barbarella, Nine to Five and On Golden Bond.
Her most recent performance was in the Netflix comedy series Grace and Frankie.
Fonda is also known as a political activist, and in the 1960s she vocally opposed the Vietnam War.
She said the effects of her recent chemotherapy “completely faded away when I went to DC for the first ever live, in-person gathering of fire drills on Friday,” as she calls on US firefighters to “demand a cleaner, greener, healthier world.”
“Thank heavens for that because it’s been a busy week,” she added, detailing her other campaign for climate and the environment.
